Clinical Research Directory

The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)

Sponsor: University of Luebeck

Summary

The entirely subcutaneous implantable defibrillator (S-ICD) (Emblem, Boston Scientific, Marlborough, MA, USA) was introduced as a new therapeutic alternative to the conventional transvenous ICD in 2009 and implantations are rapidly expanding since then.1 Implantation of the S-ICD seems to reduce implant-related perioperative complications such as pneumothorax, hematoma and cardiac tamponade. The aim of this multicenter registry is thus to assess the outcome of patients following an S-ICD implantation in a real-world setting.

Official title: The International Subcutaneous Implantable Cardioverter Defibrillator Registry (iSuSi)

Key Details

Conditions

Locations (1)